Chester County News and Community Website
Neuronetics, Inc. (NASDAQ: STIM), headquartered in Malvern, PA, is a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders.
MALVERN, PA — Neuronetics Inc. (NASDAQ: STIM) will participate in an institutional investor conference next week, providing investors with an opportunity to hear the company’s perspective on the commercialization of …
Neuronetics Joins Investor Summit as Mental Health Market Evolves Read More MALVERN, PA — Neuronetics Inc. (NASDAQ: STIM) has appointed healthcare sales executive Robert Greene as senior vice president of sales and awarded him restricted stock units valued at 200,000 shares, …
Neuronetics Names Sales Chief, Grants Equity Incentive Read More MALVERN, PA — Neuronetics, Inc. (Nasdaq: STIM) has partnered with ANT Neuro to integrate image-guided neuronavigation technology into its NeuroStar transcranial magnetic stimulation platform, as providers increasingly seek more personalized …
Neuronetics Expands NeuroStar With Navigation Partnership Read More MALVERN, PA — Neuronetics (NASDAQ: STIM) reported higher first-quarter revenue driven by growth in its U.S. clinic operations following the Greenbrook acquisition, while the company narrowed losses and reduced cash …
Neuronetics Revenue Rises as Clinic Business Expands Read More MALVERN, PA — Neuronetics, Inc. (Nasdaq: STIM) granted restricted stock unit inducement awards to six new non-executive employees under its 2020 Inducement Incentive Plan.
Neuronetics Grants Inducement Awards to Six New Employees Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) plans to release its first-quarter 2026 financial and operating results before market open on Tuesday, May 5, 2026, and will host a conference …
Neuronetics Schedules Q1 2026 Earnings Release and Call Read More MALVERN, PA — Neuronetics, Inc. (Nasdaq: STIM) said Optum, UnitedHealthcare, and United Behavioral Health recently updated a clinical policy to allow psychiatric mental health nurse practitioners to order, supervise, and …
Optum Expands TMS Policy to Include Nurse Practitioners Read More MALVERN, PA — Neuronetics Inc. (Nasdaq: STIM) said Executive Vice President, Chief Financial Officer and Treasurer Steven E. Pfanstiel will leave the company, with his departure effective May 1, 2026, …
Neuronetics CFO Steven Pfanstiel to Depart in May Read More MALVERN, PA — Neuronetics, Inc. (Nasdaq: STIM) reported higher fourth-quarter and full-year 2025 revenue, narrowed its losses, posted positive operating cash flow in the fourth quarter, and said Dan Reuvers …
Neuronetics Reports Higher Revenue, Narrows Loss, Sets 2026 Outlook Read More MALVERN, PA — Neuronetics Inc. (Nasdaq: STIM) said it has appointed Dan Reuvers as president and chief executive officer, effective Monday, succeeding Keith Sullivan, who will step down the same …
Neuronetics Appoints Dan Reuvers as CEO, Succeeding Keith Sullivan Read More